BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 456627 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 Interleukin-6 Human 10.00 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456628 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search 8W7 53328043 354327362 ZINC00384737 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456629 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 Interleukin-1 beta Homo sapiens 0.85 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456630 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 Granulocyte-macrophage colony-stimulating factor Human 9.20 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456631 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 Mediator of DNA damage checkpoint protein 1 Human 2.60 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456632 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 C-C motif chemokine 3 Human 190 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456633 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456634 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30) IXZOHGPZAQLIBH-UHFFFAOYSA-N 77001 3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4 Tumor necrosis factor Homo sapiens 1.80 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77001&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 53328043 354327362 ZINC00384737 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456635 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R Interleukin-6 Human 83 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456636 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456637 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R Interleukin-1 beta Homo sapiens 6.20 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456638 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R Granulocyte-macrophage colony-stimulating factor Human 39 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456639 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R Mediator of DNA damage checkpoint protein 1 Human 12 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456640 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R C-C motif chemokine 3 Human 450 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456641 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456642 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m1/s1 IXZOHGPZAQLIBH-OAQYLSRUSA-N 77015 (R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione::US9694015, 6.4R Tumor necrosis factor Homo sapiens 9.50 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77015&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 58389182 354327366 ZINC37867405 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456643 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S Interleukin-6 Human 3.80 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456644 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search 8W7 67335295 350083120 ZINC13133466 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456645 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S Interleukin-1 beta Homo sapiens 0.46 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456646 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S Granulocyte-macrophage colony-stimulating factor Human 2.20 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456647 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S Mediator of DNA damage checkpoint protein 1 Human 2.10 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456648 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S C-C motif chemokine 3 Human 28 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456649 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456650 O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 IXZOHGPZAQLIBH-NRFANRHFSA-N 65497 CC-220 (Compound 6)::US9694015, 6.4S Tumor necrosis factor Homo sapiens 0.59 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65497&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 8W7 7PS9,5V3O,8D80 67335295 350083120 ZINC13133466 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456651 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A Interleukin-6 Human 60 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456652 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search 835 24967599 354327359 ZINC04197025 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456653 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A Interleukin-1 beta Homo sapiens 54 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456654 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A Granulocyte-macrophage colony-stimulating factor Human 950 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456655 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A Mediator of DNA damage checkpoint protein 1 Human 62 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456656 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A C-C motif chemokine 3 Human 300 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456657 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456658 Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) RSNPAKAFCAAMBH-UHFFFAOYSA-N 76986 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione::US11059801, Compound D-17::US9694015, Compound A Tumor necrosis factor Homo sapiens 34 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=76986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=76986&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 835 7PSO 24967599 354327359 ZINC04197025 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456659 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione Interleukin-6 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456660 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search EF2 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456661 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione Interleukin-1 beta Homo sapiens >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456662 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione Granulocyte-macrophage colony-stimulating factor Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456663 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione Mediator of DNA damage checkpoint protein 1 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456664 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione C-C motif chemokine 3 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456665 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456666 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) UEJJHQNACJXSKW-UHFFFAOYSA-N 50070114 (+/-)-thalidomide::2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione::2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::CHEMBL468::K-17::THALIDOMIDE::Thalomid::US11059801, Compound D-62::[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione Tumor necrosis factor Homo sapiens >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50070114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50070114&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search EF2 4CI1,8BC7,5AMI,5AMH,7BQU,5YIZ,7PSO,4V32,4V2Y,5OH1,5AMK,5AMJ,6R13,6R12,6R19,6R18,6R1C,6R1A,6R1W,6R0U,6R0S,5YJ0,4TZC 5426 103964042 74947 CHEMBL468 DB01041 7327 C07910 ZINC01530948 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456667 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide Interleukin-6 Human 59 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456668 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana 2900 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search Y70 134780 350083086 DB08910 ZINC15953204 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456669 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide Interleukin-1 beta Homo sapiens 47 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456670 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide Granulocyte-macrophage colony-stimulating factor Human 1500 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456671 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide Mediator of DNA damage checkpoint protein 1 Human 31 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456672 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide C-C motif chemokine 3 Human 230 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456673 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456674 Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) UVSMNLNDYGZFPF-UHFFFAOYSA-N 65456 19171-19-8::4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione::Actimid::CC-4047::Pomalyst::US11059801, Compound D-4::US9694015, 6.2::pomalidomide Tumor necrosis factor Homo sapiens 33 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65456&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search Y70 7SZA 134780 350083086 DB08910 ZINC15953204 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456675 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 Interleukin-6 Human 1200 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=12&target=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=Interleukin-6&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM 1IL6,1P9M,2IL6,4CNI,4J4L,4NI7,4NI9,4O9H,4ZS7,8D82 Interleukin-6 IL6_HUMAN P05231 Q9UCU2 Q9UCU3 Q9UCU4 456676 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 Glyceraldehyde-3-phosphate dehydrogenase, cytosolic Leishmania mexicana >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000388&target=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=Glyceraldehyde-3-phosphate+dehydrogenase%2C+cytosolic&column=ki&startPg=0&Increment=50&submit=Search LVY 216326 350083085 DB00480 ZINC02508407 1 MVKVGINGFGRIGRVVFRAAQMRPDIEIVGINDLLDAEYMAYSLKYDSTHGRFDGTVEVIKGALVVNGKSIRVTSERDPANLKWDEIGVEVVVESTGLFLTQETAHKHIEAGARRVVMTGPPKDDTPMFVMGVNHTTYKGQPIISNASCTTNCLAPLAKVVNEKYGIVEGLMTTVHATTATQKTVDGPSLKDWRGGRGASQNIIPSSTGAPKAVGKVYPALDGKLTGMAFRVPTPNVSVVDLTVRLEKPATYKDICAAIKAAAEGEMKGILGYTDDEVVSSDFNGVALTSVFDVKAGISLNDHFVKLVSWYDNETGYSHKVLDLILHTSAR Glyceraldehyde-3-phosphate dehydrogenase, cytosolic G3PC_LEIME Q01558 456677 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 Interleukin-1 beta Homo sapiens 390 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=87&target=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=Interleukin-1+beta&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS 1I1B,1IOB,1ITB,1L2H,2I1B,2KH2,2NVH,3O4O,4DEP,4G6J,4G6M,4I1B,5BVP,5I1B,5R7W,5R85,5R86,5R87,5R88,5R89,5R8A,5R8B,5R8C,5R8D,5R8E,5R8F,5R8G,5R8H,5R8I,5R8J,5R8K,5R8L,5R8M,5R8N,5R8O,5R8P,5R8Q,6I1B,6Y8I,6Y8M,7CHY,7CHZ,7I1B,7Z4T,9ILB Interleukin-1 beta IL1B_HUMAN P01584 Q53X59 Q53XX2 Q7M4S7 Q7RU01 Q96HE5 Q9UCT6 456678 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 Granulocyte-macrophage colony-stimulating factor Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=295&target=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=Granulocyte-macrophage+colony-stimulating+factor&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE 1CSG,2GMF,4NKQ,4RS1,5C7X,5D70,5D71,5D72,6BFQ,6BFS Granulocyte-macrophage colony-stimulating factor CSF2_HUMAN P04141 Q14CE8 Q2VPI8 Q8NFI6 456679 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 Mediator of DNA damage checkpoint protein 1 Human 190 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=296&target=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=Mediator+of+DNA+damage+checkpoint+protein+1&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MEDTQAIDWDVEEEEETEQSSESLRCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLPFVSRGPLTVEETPRVQGETQPQRLLLAEDSEEEVDFLSERRMVKKSRTTSSSVIVPESDEEGHSPVLGGLGPPFAFNLNSDTDVEEGQQPATEEASSAARRGATVEAKQSEAEVVTEIQLEKDQPLVKERDNDTKVKRGAGNGVVPAGVILERSQPPGEDSDTDVDDDSRPPGRPAEVHLERAQPFGFIDSDTDAEEERIPATPVVIPMKKRKIFHGVGTRGPGAPGLAHLQESQAGSDTDVEEGKAPQAVPLEKSQASMVINSDTDDEEEVSAALTLAHLKESQPAIWNRDAEEDMPQRVVLLQRSQTTTERDSDTDVEEEELPVENREAVLKDHTKIRALVRAHSEKDQPPFGDSDDSVEADKSSPGIHLERSQASTTVDINTQVEKEVPPGSAIIHIKKHQVSVEGTNQTDVKAVGGPAKLLVVSLEEAWPLHGDCETDAEEGTSLTASVVADVRKSQLPAEGDAGAEWAAAVLKQERAHEVGAQGGPPVAQVEQDLPISRENLTDLVVDTDTLGESTQPQREGAQVPTGREREQHVGGTKDSEDNYGDSEDLDLQATQCFLENQGLEAVQSMEDEPTQAFMLTPPQELGPSHCSFQTTGTLDEPWEVLATQPFCLRESEDSETQPFDTHLEAYGPCLSPPRAIPGDQHPESPVHTEPMGIQGRGRQTVDKVMGIPKETAERVGPERGPLERETEKLLPERQTDVTGEEELTKGKQDREQKQLLARDTQRQESDKNGESASPERDRESLKVEIETSEEIQEKQVQKQTLPSKAFEREVERPVANRECDPAELEEKVPKVILERDTQRGEPEGGSQDQKGQASSPTPEPGVGAGDLPGPTSAPVPSGSQSGGRGSPVSPRRHQKGLLNCKMPPAEKASRIRAAEKVSRGDQESPDACLPPTVPEAPAPPQKPLNSQSQKHLAPPPLLSPLLPSIKPTVRKTRQDGSQEAPEAPLSSELEPFHPKPKIRTRKSSRMTPFPATSAAPEPHPSTSTAQPVTPKPTSQATRSRTNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTSQVTRGRKSRSSVKTPETVVPTALELQPSTSTDRPVTSEPTSQATRGRKNRSSVKTPEPVVPTAPELQPSTSTDQPVTSEPTYQATRGRKNRSSVKTPEPVVPTAPELRPSTSTDRPVTPKPTSRTTRSRTNMSSVKTPETVVPTAPELQISTSTDQPVTPKPTSRTTRSRTNMSSVKNPESTVPIAPELPPSTSTEQPVTPEPTSRATRGRKNRSSGKTPETLVPTAPKLEPSTSTDQPVTPEPTSQATRGRTNRSSVKTPETVVPTAPELQPSTSTDQPVTPEPTSQATRGRTDRSSVKTPETVVPTAPELQASASTDQPVTSEPTSRTTRGRKNRSSVKTPETVVPAAPELQPSTSTDQPVTPEPTSRATRGRTNRSSVKTPESIVPIAPELQPSTSRNQLVTPEPTSRATRCRTNRSSVKTPEPVVPTAPEPHPTTSTDQPVTPKLTSRATRRKTNRSSVKTPKPVEPAASDLEPFTPTDQSVTPEAIAQGGQSKTLRSSTVRAMPVPTTPEFQSPVTTDQPISPEPITQPSCIKRQRAAGNPGSLAAPIDHKPCSAPLEPKSQASRNQRWGAVRAAESLTAIPEPASPQLLETPIHASQIQKVEPAGRSRFTPELQPKASQSRKRSLATMDSPPHQKQPQRGEVSQKTVIIKEEEEDTAEKPGKEEDVVTPKPGKRKRDQAEEEPNRIPSRSLRRTKLNQESTAPKVLFTGVVDARGERAVLALGGSLAGSAAEASHLVTDRIRRTVKFLCALGRGIPILSLDWLHQSRKAGFFLPPDEYVVTDPEQEKNFGFSLQDALSRARERRLLEGYEIYVTPGVQPPPPQMGEIISCCGGTYLPSMPRSYKPQRVVITCPQDFPHCSIPLRVGLPLLSPEFLLTGVLKQEAKPEAFVLSPLEMSST 2ADO,2AZM,2ETX,3UMZ,3UN0,3UNM,3UNN,3UOT Mediator of DNA damage checkpoint protein 1 MDC1_HUMAN Q14676 A2AB04 A2BF04 A2RRA8 A7YY86 B0S8A2 Q0EFC2 Q2L6H7 Q2TAZ4 Q5JP55 Q5JP56 Q5ST83 Q68CQ3 Q86Z06 Q96QC2 456680 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 C-C motif chemokine 3 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=297&target=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=C-C+motif+chemokine+3&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 2X69,3H44,4ZKB,5COR,5D65 C-C motif chemokine 3 CCL3_HUMAN P10147 456681 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 C-C motif chemokine 4 Human >10000 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=298&target=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=C-C+motif+chemokine+4&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 1HUM,1HUN,2FFK,2FIN,2X6L,4RAL C-C motif chemokine 4 CCL4_HUMAN P13236 P22617 Q13704 Q3SXL8 Q6FGI8 456682 Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) GOTYRUGSSMKFNF-UHFFFAOYSA-N 65454 191732-72-6::CC-5013::Lenalidomide::Revimid::Revlimid::US11530219, Compound Lenalidomide::US9694015, 6.1 Tumor necrosis factor Homo sapiens 220 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=65454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=65454&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search LVY 4CI2,5FQD,4V30,4TZ4 216326 350083085 DB00480 ZINC02508407 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456683 O=C1N(Cc2c1cccc2OCc1ccc(OCCN2CCCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C26H29N3O5/c30-24-11-10-22(25(31)27-24)29-16-21-20(26(29)32)4-3-5-23(21)34-17-18-6-8-19(9-7-18)33-15-14-28-12-1-2-13-28/h3-9,22H,1-2,10-17H2,(H,27,30,31) FMKVJIORFDDBBM-UHFFFAOYSA-N 77003 3-(1-oxo-4-(4-(2-(pyrrolidin-1-yl)ethoxy)benzyloxy)isoindolin-2-yl)-piperidine-2,6-dione::US9694015, 6.5::US9694015, Compound B Tumor necrosis factor Homo sapiens 0.52 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77003&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 67335495 354327363 ZINC02879809 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456684 O=C1N(Cc2c1cccc2OCc1ccc(OCCN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C26H29N3O6/c30-24-9-8-22(25(31)27-24)29-16-21-20(26(29)32)2-1-3-23(21)35-17-18-4-6-19(7-5-18)34-15-12-28-10-13-33-14-11-28/h1-7,22H,8-17H2,(H,27,30,31) ADGAJEWJLBZHMT-UHFFFAOYSA-N 77005 3-(4-(4-(2-morpholin-4-yl-ethoxy)-benzyloxy)-1-oxoisoindolin-2-yl)-piperidine-2,6-dione::US9694015, 6.6 Tumor necrosis factor Homo sapiens 0.96 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77005&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 67335448 354327364 ZINC00917916 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 456685 O=C1N(Cc2c1cccc2OCc1ccc(CCN2CCOCC2)cc1)C1CCC(=O)NC1=O InChI=1S/C26H29N3O5/c30-24-9-8-22(25(31)27-24)29-16-21-20(26(29)32)2-1-3-23(21)34-17-19-6-4-18(5-7-19)10-11-28-12-14-33-15-13-28/h1-7,22H,8-17H2,(H,27,30,31) NAZVYHJDSYBQMH-UHFFFAOYSA-N 77008 3-{4-[4-(2-morpholin-4-yl-ethyl)-benzyloxy]-1-oxo-1,3-dihydro-isoindol-2-yl}-piperidine-2,6-dione::US9694015, 6.7 Tumor necrosis factor Homo sapiens 0.79 37.00 C US Patent 10.7270/Q2R49NZN aid1794873 US9694015 Gandhi, A; Dimartino, J; Chopra, R 7/4/2017 1/19/2018 Celgene Corporation http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=77008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=77008&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 58389300 354327365 ZINC02871298 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3